Literature DB >> 18036934

Hyperglycemia after infant cardiac surgery does not adversely impact neurodevelopmental outcome.

Jean A Ballweg1, Gil Wernovsky, Richard F Ittenbach, Judy Bernbaum, Marsha Gerdes, Paul R Gallagher, Troy E Dominguez, Elaine Zackai, Robert R Clancy, Susan C Nicolson, Thomas L Spray, J William Gaynor.   

Abstract

BACKGROUND: Hyperglycemia has been associated with worse outcome after traumatic brain injury and cardiac surgery in adults. It is not known whether postoperative hyperglycemia results in worse neurodevelopmental outcome after infant cardiac surgery.
METHODS: Secondary analysis of postoperative glucose levels was performed in infants younger than 6 months of age enrolled in a prospective study of genetic polymorphisms and neurodevelopmental outcomes who were undergoing repair of two-ventricle cardiac defects. Neurodevelopmental outcomes at 1 year of age were assessed with the Bayley Scales of Infant Development-II, yielding two indices: Mental Developmental Index and Psychomotor Developmental Index.
RESULTS: Surgical repair was performed in 247 infants with 1 in-hospital and 3 late deaths. Neurodevelopmental evaluation was performed in 188 of 243 (77%) survivors. Glucose levels at cardiac intensive care unit admission and during the first 48 postoperative hours were available for 180 of 188 patients. Mean admission glucose was 328 +/- 106 mg/dL; maximum glucose was 340 +/- 109 mg/dL. At least one glucose was greater than 200 mg/dL in 160 of 180 patients, and 49 of 180 patients (27%) had a glucose greater than 400 mg/dL. Only 1 patient had a glucose less than 50 mg/dL. Female sex (p = 0.02), but no other patient or operative variable, was associated with higher glucose levels. Mean Mental Developmental Index and Psychomotor Developmental Index were 90.6 +/- 14.9 and 81.6 +/- 17.2, respectively. Hyperglycemia was not associated with lower Mental Developmental Index and Psychomotor Developmental Index scores for the entire cohort or for neonates alone.
CONCLUSIONS: Hyperglycemia is common early after infant cardiac surgery, but is not associated with worse neurodevelopmental outcome at 1 year of age.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18036934     DOI: 10.1016/j.athoracsur.2007.06.099

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  13 in total

Review 1.  Stress hyperglycemia in pediatric critical illness: the intensive care unit adds to the stress!

Authors:  Vijay Srinivasan
Journal:  J Diabetes Sci Technol       Date:  2012-01-01

2.  Design and rationale of safe pediatric euglycemia after cardiac surgery: a randomized controlled trial of tight glycemic control after pediatric cardiac surgery.

Authors:  Michael G Gaies; Monica Langer; Jamin Alexander; Garry M Steil; Janice Ware; David Wypij; Peter C Laussen; Jane W Newburger; Caren S Goldberg; Frank A Pigula; Avinash C Shukla; Christopher P Duggan; Michael S D Agus
Journal:  Pediatr Crit Care Med       Date:  2013-02       Impact factor: 3.624

Review 3.  Neurodevelopmental Outcomes in Children With Congenital Heart Disease-What Can We Impact?

Authors:  Gil Wernovsky; Daniel J Licht
Journal:  Pediatr Crit Care Med       Date:  2016-08       Impact factor: 3.624

Review 4.  Endocrinologic Diseases in Pediatric Cardiac Intensive Care.

Authors:  Carmen L Soto-Rivera; Steven M Schwartz; Jaclyn E Sawyer; Duncan J Macrae; Michael S D Agus
Journal:  Pediatr Crit Care Med       Date:  2016-08       Impact factor: 3.624

Review 5.  Pediatric Multiple Organ Dysfunction Syndrome: Promising Therapies.

Authors:  Allan Doctor; Jerry Zimmerman; Michael Agus; Surender Rajasekaran; Juliane Bubeck Wardenburg; James Fortenberry; Anne Zajicek; Emma Mairson; Katri Typpo
Journal:  Pediatr Crit Care Med       Date:  2017-03       Impact factor: 3.624

6.  Tight glycemic control after pediatric cardiac surgery in high-risk patient populations: a secondary analysis of the safe pediatric euglycemia after cardiac surgery trial.

Authors:  Michael S D Agus; Lisa A Asaro; Garry M Steil; Jamin L Alexander; Melanie Silverman; David Wypij; Michael G Gaies
Journal:  Circulation       Date:  2014-03-26       Impact factor: 29.690

7.  Hyperglycaemia after Stage I palliation does not adversely affect neurodevelopmental outcome at 1 year of age in patients with single-ventricle physiology.

Authors:  Jean A Ballweg; Richard F Ittenbach; Judy Bernbaum; Marsha Gerdes; Troy E Dominguez; Elaine H Zackai; Robert R Clancy; James William Gaynor
Journal:  Eur J Cardiothorac Surg       Date:  2009-08-20       Impact factor: 4.191

8.  Impact of Tight Glycemic Control on Neurodevelopmental Outcomes at 1 Year of Age for Children with Congenital Heart Disease: A Randomized Controlled Trial.

Authors:  Anjali Sadhwani; Lisa A Asaro; Caren Goldberg; Janice Ware; Jennifer Butcher; Michael Gaies; Cynthia Smith; Jamin L Alexander; David Wypij; Michael S D Agus
Journal:  J Pediatr       Date:  2016-04-23       Impact factor: 4.406

9.  Tight glycemic control versus standard care after pediatric cardiac surgery.

Authors:  Michael S D Agus; Garry M Steil; David Wypij; John M Costello; Peter C Laussen; Monica Langer; Jamin L Alexander; Lisa A Scoppettuolo; Frank A Pigula; John R Charpie; Richard G Ohye; Michael G Gaies
Journal:  N Engl J Med       Date:  2012-09-07       Impact factor: 91.245

10.  Association between intraoperative and early postoperative glucose levels and adverse outcomes after complex congenital heart surgery.

Authors:  Angelo Polito; Ravi R Thiagarajan; Peter C Laussen; Kimberlee Gauvreau; Michael S D Agus; Mark A Scheurer; Frank A Pigula; John M Costello
Journal:  Circulation       Date:  2008-11-10       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.